Lili Belcastro
Associate Director Bristol Myers Squibb
Seminars
Thursday 9th October 2025
Strengthening Raw Material Quality and Supply Chain Confidence Through USP Standards
9:45 am
- Outlining USP’s role in defining quality expectations for raw materials used in pharmaceutical and biologic manufacturing
- Discussing how USP standards, reference materials, and tools help reduce variability and improve supplier qualification
- Highlighting ongoing initiatives to support risk-based raw material control and global regulatory alignment
Thursday 9th October 2025
Panel Discussion: Shaping the Future of Ancillary Materials in Cell & Gene Therapy Insights from ISO Standard Development
9:00 am
- Firsthand experience contributing to a new ISO standard, focused on ancillary materials used in advanced therapies
- Overview of the U.S. TAG validation process and transition to a New Work Item Proposal within the ISO framework
- What this upcoming standard means for developers, manufacturers, and regulators over the next 3 to 4 years
Thursday 9th October 2025
Chair’s Opening Remarks
9:00 am
Thursday 9th October 2025
Chair’s Closing Remarks
4:15 pm
